Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Expert Opinion on Investigational Drugs
|
May 16, 2007
Aripiprazole acts as a selective dopamine D2 receptor partial agonist
Martyn Wood, Charlie Reavill
Pharmacology & Therapeutics
|
December 18, 2007
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J Langmead, Jeannette Watson, Charlie Reavill
Journal of Psychopharmacology (Oxford, England)
|
June 27, 2007
(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics
Jackie Cilia, Paula Hatcher, Charlie Reavill, et al.
Psychopharmacology
|
December 8, 2005
Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data
Claire Rourke, Kathryn R Starr, Charlie Reavill, et al.
Synapse (New York, N.Y.)
|
May 31, 2008
Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats
Claire Bloomfield, Sarah J French, Declan N C Jones, et al.
Brain Research
|
April 9, 2002
The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585
Jennifer C Roberts, Charlie Reavill, Simon Z East, et al.
Psychopharmacology
|
July 8, 2005
Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist
Jackie Cilia, Jane E Cluderay, Melanie J Robbins, et al.
European Journal of Pharmacology
|
August 24, 2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties
Martyn D Wood, Claire Scott, Kirsten Clarke, et al.
Behavioural Pharmacology
|
November 21, 2008
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat
Marie L Woolley, Kerry A Waters, Charlie Reavill, et al.
Psychopharmacology
|
September 3, 2008
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040
Eric Southam, Jackie Cilia, Jane E Gartlon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Expert Opinion on Investigational Drugs
|
May 16, 2007
Aripiprazole acts as a selective dopamine D2 receptor partial agonist
Martyn Wood, Charlie Reavill
Pharmacology & Therapeutics
|
December 18, 2007
Muscarinic acetylcholine receptors as CNS drug targets
Christopher J Langmead, Jeannette Watson, Charlie Reavill
Journal of Psychopharmacology (Oxford, England)
|
June 27, 2007
(+/-) Ketamine-induced prepulse inhibition deficits of an acoustic startle response in rats are not reversed by antipsychotics
Jackie Cilia, Paula Hatcher, Charlie Reavill, et al.
Psychopharmacology
|
December 8, 2005
Effects of the atypical antipsychotics olanzapine and risperidone on plasma prolactin levels in male rats: a comparison with clinical data
Claire Rourke, Kathryn R Starr, Charlie Reavill, et al.
Synapse (New York, N.Y.)
|
May 31, 2008
Chandelier cartridges in the prefrontal cortex are reduced in isolation reared rats
Claire Bloomfield, Sarah J French, Declan N C Jones, et al.
Brain Research
|
April 9, 2002
The distribution of 5-HT(6) receptors in rat brain: an autoradiographic binding study using the radiolabelled 5-HT(6) receptor antagonist [(125)I]SB-258585
Jennifer C Roberts, Charlie Reavill, Simon Z East, et al.
Psychopharmacology
|
July 8, 2005
Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist
Jackie Cilia, Jane E Cluderay, Melanie J Robbins, et al.
European Journal of Pharmacology
|
August 24, 2006
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties
Martyn D Wood, Claire Scott, Kirsten Clarke, et al.
Behavioural Pharmacology
|
November 21, 2008
Selective dopamine D4 receptor agonist (A-412997) improves cognitive performance and stimulates motor activity without influencing reward-related behaviour in rat
Marie L Woolley, Kerry A Waters, Charlie Reavill, et al.
Psychopharmacology
|
September 3, 2008
Preclinical investigations into the antipsychotic potential of the novel histamine H3 receptor antagonist GSK207040
Eric Southam, Jackie Cilia, Jane E Gartlon, et al.
Page
of 2